Vontobel Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Vontobel Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-139,683	Closed	-$13.9M	–	68
2018 Q2	$13.9M	Sell	139,683 -734,285	-84%	-$63.4M	0.1%	62
2018 Q1	$71.5M	Buy	873,968 +786,122	+895%	+$63.5M	0.51%	39
2017 Q4	$6.92M	Buy	87,846 +30,918	+54%	+$2.57M	0.05%	59
2017 Q3	$5.25M	Buy	56,928 +6,067	+12%	+$583K	0.04%	58
2017 Q2	$5.75M	Sell	50,861 -6,439	-11%	-$720K	0.04%	55
2017 Q1	$5.74M	Buy	+57,300	New	+$6.12M	0.05%	54

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vontobel Asset Management's CBPO Position: Q3 2018 in Review

Vontobel Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 139,683 shares — an estimated $13.9M sold.

Vontobel Asset Management first reported a position in CBPO in Q1 2017 and held it in 6 quarters. The position peaked at $71.5M in Q1 2018. 83 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Vontobel Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Vontobel Asset Management sold 139,683 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $13.9M.
Vontobel Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 6 quarters.
Vontobel Asset Management's China Biologic Products Holdings, Inc. position peaked at $71.5M in Q1 2018.
83 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Vontobel Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.